文献速递气道管理

6种局部药物预防气管插管后咽喉痛疗效比较:系统综述与网络Meta分析

Comparative Efficacy of 6 Topical Pharmacological Agents for Preventive Interventions of Postoperative Sore Throat After Tracheal Intubation: A Systematic Review and Network Meta-analysis.
PubMed 文献 · Anesth Analg · 2021-01-01

除利多卡因外,其余预防干预在4个时间间隔均优于安慰剂;利多卡因仅在术后2-3小时有预防效果。结论提示利多卡因并非局部预防POST的最优选择,糖皮质激素、NSAIDs、甘草及NMDA受体拮抗剂(氯胺酮和镁)均可减少术后咽痛。

要点

  • 除利多卡因外,其余局部预防药物在4个术后时间间隔均优于安慰剂。
  • 利多卡因仅在术后2-3小时有预防POST效果,并非最优局部用药。
  • 糖皮质激素、NSAIDs、甘草及NMDA受体拮抗剂均可减少术后咽痛。

核心结论

  • 在研究的6种局部药物中,利多卡因并非预防POST的最优选择。
  • 甘草、糖皮质激素、NSAIDs及NMDA受体拮抗剂(氯胺酮和镁)在4个术后时间间隔均与术后咽痛减少相关。
  • 上述药物可根据麻醉医师临床经验和患者偏好选择用于减少术后咽痛。

研究设计与样本

  • 系统综述与网络Meta分析,检索PubMed、Embase、Web of Science和Cochrane Library截至2019年9月8日的文献。
  • 主要结局为POST风险,采用GRADE系统评估证据质量,研究注册号PROSPERO CRD42020158985。

主要发现

  • 除利多卡因外,所有预防干预在4个时间间隔均比安慰剂更有效。
  • 利多卡因仅在术后2-3小时时间间隔比安慰剂有更好的POST预防效果(OR:0.35,95%CrI:0.16-0.79)。
  • 除2-3小时外,糖皮质激素、氯胺酮、镁、NSAIDs和甘草相对于利多卡因的POST风险更低。
  • 术后24小时/拔管后24小时,镁通常比氯胺酮获益更大(OR:0.41,95%CrI:0.18-0.92)。
  • 与氯胺酮相比,糖皮质激素在4-6小时(OR:0.40,95%CrI:0.19-0.83)和24小时(OR:0.34,95%CrI:0.16-0.72)时间间隔与POST风险降低相关。

关键数值与推荐

  • 利多卡因 vs 安慰剂术后2-3小时:OR 0.35(95%CrI 0.16-0.79)。
  • 镁 vs 氯胺酮术后24小时/拔管后24小时:OR 0.41(95%CrI 0.18-0.92)。
  • 糖皮质激素 vs 氯胺酮术后4-6小时:OR 0.40(95%CrI 0.19-0.83);术后24小时:OR 0.34(95%CrI 0.16-0.72)。
  • 甘草 vs 镁术后2-3小时:OR 0.38(95%CrI 0.15-0.97)。

临床怎么用

  • 局部预防POST可优先考虑糖皮质激素、NSAIDs、甘草或NMDA受体拮抗剂(氯胺酮和镁),而非利多卡因。
  • 药物选择可结合麻醉医师临床经验与患者偏好。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Topical pharmacological agents typically used to treat postoperative sore throat (POST) after tracheal intubation include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, lidocaine, Glycyrrhiza (licorice), and N-methyl-d-aspartate (NMDA) receptor antagonists (including ketamine and magnesium). However, the optimal prophylactic drug remains elusive. METHODS: The literature published before September 8, 2019 was searched on the PubMed, the Embase, the Web of Science, and the Cochrane Library. Randomized controlled trials (RCTs) covering topical prophylactic medications for patients with POST were included. Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was used to assess the quality of evidence. The primary outcome is the risk of POST. Combining both direct and indirect evidence, a network meta-analysis was performed to assess odds ratios (ORs) between the topical pharmacological agents and surface under the cumulative ranking (SUCRA) curve for the treatment-based outcomes. This study is registered with PROSPERO, number CRD42020158985. RESULTS: Sixty-two RCTs (at least 73% of which were double blinded) that included a total of 6708 subjects and compared 6 categories of drugs and/or placebos were ultimately enrolled. All preventive interventions except lidocaine were more effective than placebo at the 4 time intervals. Lidocaine (OR: 0.35, 95% credible interval [CrI], 0.16-0.79) has a greater POST preventative intervention effect than the placebo at a time interval of only 2 to 3 hours after surgery. Relative to lidocaine, the risk of POST except 2 to 3 hours was lower for the following treatments: corticosteroids, ketamine, magnesium, NSAIDs, and Glycyrrhiza. The NMDA receptor antagonists studied here included ketamine and magnesium. Magnesium generally demonstrated greater benefit than ketamine at 24 hours postsurgery/extubation (OR: 0.41, 95% CrI, 0.18-0.92). Compared with ketamine, corticosteroids were associated with a reduced risk of POST during the 4 to 6 hours (OR: 0.40, 95% CrI, 0.19-0.83) and 24 hours (OR: 0.34, 95% CrI, 0.16-0.72) time intervals. During the 2 to 3 hours time interval, Glycyrrhiza (OR: 0.38, 95% CrI, 0.15-0.97) was more efficacious than magnesium. CONCLUSIONS: Our analysis shows that, among the 6 topical medications studied, lidocaine is not optimal for topical use to prevent POST. Glycyrrhizin, corticosteroids, NSAIDs, and NMDA receptor antagonists (ketamine and magnesium) are associated with a reduced postoperative pharyngeal pain across the 4 postsurgical time intervals studied, all of which can be chosen according to the clinical experience of the anesthesiologists and the patient preferences and are recommended for the reduction of postoperative throat pain.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Wang G, Qi Y, Wu L, et al. Comparative Efficacy of 6 Topical Pharmacological Agents for Preventive Interventions of Postoperative Sore Throat After Tracheal Intubation: A Systematic Review and Network Meta-analysis. Anesth Analg. 2021. PMID: 33886521. doi:10.1213/ANE.0000000000005521

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。